Quarterly report pursuant to Section 13 or 15(d)

Composition of Certain Financial Statement Items Equity Method and Non-marketable Equity Investments (Details)

v3.19.1
Composition of Certain Financial Statement Items Equity Method and Non-marketable Equity Investments (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2019
Sep. 30, 2018
Equity Method and Non-marketable Equity Investments [Line Items]    
Equity method investments $ 354 $ 402
Non-marketable equity investments 779 650
Carrying value of equity method and non-marketable equity investments $ 1,133 $ 1,052
Equity Method Investee [Member]    
Equity Method and Non-marketable Equity Investments [Line Items]    
Non-cash consideration received from equity method investee 98  
Other Restructuring [Member]    
Equity Method and Non-marketable Equity Investments [Line Items]    
Non-cash consideration received for divestiture $ 53